Theravance Biopharma, Inc. Payments for Postemployment Benefits
Theravance Biopharma, Inc. (TBPH) reported Payments for Postemployment Benefits of $3.40 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForPostemploymentBenefits · last filed 2019-08-05
- Theravance Biopharma, Inc. payments for postemployment benefits for the quarter ending 2019-06-30 was $0.00.
- Theravance Biopharma, Inc. payments for postemployment benefits for the quarter ending 2019-03-31 was $3.40M.
| Period end | Payments for Postemployment Benefits 3 month | Payments for Postemployment Benefits 6 month |
|---|---|---|
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $3.40M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $3.40M 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |